 |
|
Clinical Implications of Enzyme-Mediated Alterations of  -Aminobutyric Acid Content in Human CSF
Theodore A. Hare, PhD;
James H. Wood, MD;
Bala V. Manyam, MD
Arch Neurol. 1981;38(8):491-494.
Abstract
• Pooled samples of lumbar CSF from nine patients with neurologic disorders were aliquoted and subjected to the differential influence of temperature for four hours. The determination of the  -aminobutyric acid (GABA) levels in CSF by ion-exchange-fluorometric analysis before and after incubation showed a progressive increase in GABA content of CSF as a function of temperature, reaching a maximum at 50 °C. However, no increases in GABA level were noted in CSF incubated at 80 °C or 100 °C. These in vitro increases in the GABA content of untreated CSF appear to be entirely secondary to enzyme action, subject to individual and temperature variability, and necessitate standardization of clinical CSF protocols.
Author Affiliations
From the Departments of Pharmacology (Dr Hare) and Neurology (Dr Manyam), Jefferson Medical College of Thomas Jefferson University, Philadelphia; the Division of Neurosurgery (Dr Wood), University of Pennsylvania School of Medicine, Philadelphia; and the Neurology Service (Dr Manyam), Veterans Administration Medical and Regional Office Center, Wilmington, Del.
Footnotes
Accepted for publication Oct 21, 1980.
Reprint requests to Department of Pharmacology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 19107 (Dr Hare).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Brain {gamma}-Aminobutyric Acid Abnormality in Tardive Dyskinesia: Reduction in Cerebrospinal Fluid GABA Levels and Therapeutic Response to GABA Agonist Treatment
Thaker et al.
Arch Gen Psychiatry 1987;44:522-529.
ABSTRACT
|
